{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:24:00Z","timestamp":1785259440061,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011781","name":"Shriners Children's","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bone.2025.117541","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T19:52:44Z","timestamp":1747857164000},"page":"117541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Markedly discordant hypophosphatasia in a young girl"],"prefix":"10.1016","volume":"199","author":[{"given":"Vikram","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Elbabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"de Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Mumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2025.117541_bb0005","unstructured":"Online Mendelian Inheritance in Man, OMIM\u00ae. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), World Wide Web URL: http:\/\/omim.org\/. Accessed December 15, 2024."},{"key":"10.1016\/j.bone.2025.117541_bb0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2025.117541_bb0015","unstructured":"Whyte, MP. Hypophosphatasia and how alkaline phosphatase promotes mineralization. In: \u201cGenetics of Bone Biology and Skeletal Disease\u201d (3rd ed.), Thakker, RV, Whyte, MP, Eisman, J, Igarashi, T (eds). Elsevier (Academic Press), San Diego, CA, (in press)."},{"key":"10.1016\/j.bone.2025.117541_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia: aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2025.117541_bb0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3276003","article-title":"Structural and functional roles of glycosylphosphatidy-linositol in membranes","volume":"239","author":"Low","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bone.2025.117541_bb0030","doi-asserted-by":"crossref","first-page":"116204","DOI":"10.1016\/j.bone.2021.116204","article-title":"Hypophosphatasia: vitamin B6 status of affected children and adults","volume":"154","author":"Whyte","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117541_bb0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","article-title":"Excretion of inorganic pyrophosphate in hypophosphatasia","volume":"10","author":"Russell","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2025.117541_bb0040","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2025.117541_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.1752","article-title":"Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy","volume":"28","author":"Otero","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117541_bb0050","unstructured":"Whyte, MP. Chapter 66. Hypophosphatasia: nature's window on alkaline phosphatase function in humans, In \u201cPrinciples of Bone Biology\u201d (4th ed.). Bilezikian, JP, Raisz, LG, Martin, TJ, eds; Elsevier, pps: 1525\u201355, 2020."},{"issue":"10","key":"10.1016\/j.bone.2025.117541_bb0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bone.2025.117541_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","article-title":"Asfotase alfa for infants and young children with hypophosphatasia: 7\u00a0year outcomes of a single-arm, open-label, phase 2 extension trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2025.117541_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00381-008-0708-3","article-title":"Neurosurgical aspects of childhood hypophosphatasia","volume":"25","author":"Collmann","year":"2009","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.bone.2025.117541_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25\u00a0years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117541_bb0075","doi-asserted-by":"crossref","first-page":"116947","DOI":"10.1016\/j.bone.2023.116947","article-title":"The Global ALPL gene variant classification project: Dedicated to deciphering variants","volume":"178","author":"Farman","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117541_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2018.01.022","article-title":"Hypophosphatasia: biochemical hallmarks validate the expanded pediatric clinical nosology","volume":"110","author":"Whyte","year":"2018","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2025.117541_bb0085","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ejhg.2014.10","article-title":"Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia","volume":"22","author":"Hofmann","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2025.117541_bb0090","first-page":"1","article-title":"Challenges in hypophosphatasia: suspicion, diagnosis, genetics, management, and follow-up","author":"Montero-Lopez","year":"2024","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bone.2025.117541_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3476(86)80773-9","article-title":"Infantile hypophosphatasia: normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization (evidence for an intact structural gene for tissue nonspecific alkaline phosphatase)","volume":"108","author":"Whyte","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2025.117541_bb0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jpeds.2006.01.031","article-title":"Homozygosity for TNSALP mutation 1348C>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry","volume":"148","author":"Whyte","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2025.117541_bb0105","doi-asserted-by":"crossref","first-page":"115300","DOI":"10.1016\/j.bone.2020.115300","article-title":"Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia","volume":"134","author":"Whyte","year":"2020","journal-title":"Bone"},{"issue":"23","key":"10.1016\/j.bone.2025.117541_bb0110","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2025.117541_bb0115","doi-asserted-by":"crossref","first-page":"116007","DOI":"10.1016\/j.bone.2021.116007","article-title":"Vitamin B6 deficiency with normal plasma levels of pyridoxal 5\u2032-phosphate in perinatal hypophosphatasia","volume":"150","author":"Whyte","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117541_bb0120","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/jbmr.3377","article-title":"Validation of a novel scoring system for changes in skeletal manifestations of hypophosphatasia in newborns, infants, and children: the radiographic global impression of change scale","volume":"33","author":"Whyte","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117541_bb0125","doi-asserted-by":"crossref","first-page":"117033","DOI":"10.1016\/j.bone.2024.117033","article-title":"Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase\u2019s role in vitamin B6 metabolism","volume":"181","author":"Whyte","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117541_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ajcn\/75.1.57","article-title":"Elevated plasma 4-pyridoxic acid in renal insufficiency","volume":"75","author":"Coburn","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"24","key":"10.1016\/j.bone.2025.117541_bb0135","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1016\/S0021-9258(18)37885-2","article-title":"Structure of the human liver\/bone\/kidney alkaline phosphatase gene","volume":"263","author":"Weiss","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2025.117541_bb0140","first-page":"73","article-title":"Outcome of perinatal hypophosphatasia in Manitoba Mennonites: a retrospective cohort analysis","volume":"11","author":"Leung","year":"2013","journal-title":"J. Inherit. Metab. Dis. Rep."},{"key":"10.1016\/j.bone.2025.117541_bb0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bone.2025.117541_bb0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2019.01.049","article-title":"Natural history of perinatal and infantile hypophosphatasia: a retrospective study","volume":"209","author":"Whyte","year":"2019","journal-title":"J. Pediatr."},{"issue":"Web Server issue","key":"10.1016\/j.bone.2025.117541_bb0155","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.1093\/nar\/gks539","article-title":"Sift web server: predicting effects of amino acid substitutions on proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bone.2025.117541_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bone.2025.117541_bb0165","doi-asserted-by":"crossref","first-page":"115695","DOI":"10.1016\/j.bone.2020.115695","article-title":"Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia","volume":"142","author":"Durrough","year":"2021","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2025.117541_bb0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jbmr\/zjae098","article-title":"Pediatric hypophosphatasia: avoid diagnosis missteps!","volume":"39","author":"Whyte","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117541_bb0175","series-title":"Alkaline Phosphatase","author":"McComb","year":"1979"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2025.117541_bb0180","article-title":"Hypophosphatasia: serum alkaline phosphatase activity, plasma pyridoxal 5\u2032-phosphate levels, and ALPL gene findings in parents of affected children (abstract)","volume":"36","author":"Salles","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117541_bb0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM196909112811107","article-title":"Pseudohypophosphatasia","volume":"281","author":"Scriver","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2025.117541_bb0190","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198604103141515","article-title":"Increased serum pyridoxa1-5\u2032-phosphate in pseudohypophosphatasia","volume":"314","author":"Cole","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2025.117541_bb0195","first-page":"S242","article-title":"c.1250A>G, p.N417S is a common American TNSALP mutation involved in all clinical forms of hypophosphatasia (HPP), including pseudo-HPP","volume":"23","author":"Wenkert","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2025.117541_bb0200","first-page":"S190","article-title":"Pseudohypophosphatasia: mutation identification and 46-year follow-up of the original patient","volume":"30","author":"Madson","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2025.117541_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0009-8981(83)80005-9","article-title":"Pyridoxal 5\u2032-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients","volume":"127","author":"Lacour","year":"1983","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.bone.2025.117541_bb0210","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/sdi.12099","article-title":"Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review","volume":"26","author":"Clase","year":"2013","journal-title":"Semin. Dial."},{"issue":"4","key":"10.1016\/j.bone.2025.117541_bb0215","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/ki.1989.249","article-title":"Vitamin B6 requirements of patients on chronic peritoneal dialysis","volume":"36","author":"Ross","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2025.117541_bb0220","first-page":"S56","article-title":"Metabolism of vitamin B6 and its requirement in chronic renal failure","volume":"62","author":"Mydlik","year":"1997","journal-title":"Kidney Int. Suppl."},{"issue":"e85971","key":"10.1016\/j.bone.2025.117541_bb0225","first-page":"1","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2025.117541_bb0230","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"\u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117541_bb0235","article-title":"Bilateral atypical femoral fractures during denosumab therapy in a patient with adult-onset hypophosphatasia","volume":"2021","author":"Warren","year":"2021","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"1","key":"10.1016\/j.bone.2025.117541_bb0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/physrev.1996.76.1.127","article-title":"Defining the roles of parathyroid hormone-related protein in normal physiology","volume":"76","author":"Philbrick","year":"1996","journal-title":"Physiol. Rev."},{"issue":"7730","key":"10.1016\/j.bone.2025.117541_bb0245","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-018-0662-5","article-title":"Resting zone of the growth plate houses a unique class of skeletal stem cells","volume":"563","author":"Mizuhashi","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bone.2025.117541_bb0250","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ki.1993.193","article-title":"Accumulation of carboxy-terminal fragments of parathyroid hormone-related protein in renal failure","volume":"43","author":"Orloff","year":"1993","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bone.2025.117541_bb0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03165025","article-title":"Circulating forms of immunoreactive parathyroid hormone-related protein for identifying patients with humoral hypercalcemia of malignancy: a comparative study with C-terminal(109-141)- and N-terminal(1-86)-region-specific PTHrP radioassay","volume":"8","author":"Suehiro","year":"1994","journal-title":"Ann. Nucl. Med."},{"issue":"2","key":"10.1016\/j.bone.2025.117541_bb0260","first-page":"280","article-title":"Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening","volume":"46","author":"Chodirker","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2025.117541_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clinbiochem.2022.04.005","article-title":"Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancy","volume":"105","author":"Ashrafzadeh-Kian","year":"2022","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bone.2025.117541_bb0270","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jalm\/jfz007","article-title":"Interference of asfotase alfa in immunoassays employing alkaline phosphatase technology","volume":"5","author":"Piec","year":"2020","journal-title":"J. Appl. Lab. Med."},{"issue":"5","key":"10.1016\/j.bone.2025.117541_bb0275","doi-asserted-by":"crossref","first-page":"luae074","DOI":"10.1210\/jcemcr\/luae074","article-title":"Hypercalcemia secondary to elevated PTHrP in an infant followed by progression to nephrotic syndrome","volume":"2","author":"Gimeno","year":"2024","journal-title":"Jcem Case Rep."},{"key":"10.1016\/j.bone.2025.117541_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40697-015-0052-y","article-title":"Pthrp-related hypercalcaemia in infancy and congenital anomalies of the kidney and urinary tract (CAKUT)","volume":"2","author":"Kodous","year":"2015","journal-title":"Can. J. Kidney Health Dis."},{"key":"10.1016\/j.bone.2025.117541_bb0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.vh.2016.02.001","article-title":"The FGF23\/KLOTHO regulatory network and its roles in human disorders","volume":"101","author":"Kinoshita","year":"2016","journal-title":"Vitam. Horm."},{"issue":"1","key":"10.1016\/j.bone.2025.117541_bb0290","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12882-021-02311-3","article-title":"Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD","volume":"22","author":"Kritmetapak","year":"2021","journal-title":"BMC Nephrol."},{"issue":"12","key":"10.1016\/j.bone.2025.117541_bb0295","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00198-021-06025-y","article-title":"Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa","volume":"32","author":"Seefried","year":"2021","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2025.117541_bb0300","doi-asserted-by":"crossref","first-page":"7518789","DOI":"10.1155\/2017\/7518789","article-title":"NPHS2 mutations: a closer look to Latin American countries","volume":"2017","author":"Guaragna","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.bone.2025.117541_bb0305","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ki.2008.650","article-title":"Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant","volume":"75","author":"Machuca","year":"2009","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bone.2025.117541_bb0310","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI0216242","article-title":"NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele","volume":"110","author":"Tsukaguchi","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bone.2025.117541_bb0315","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00467-013-2542-4","article-title":"NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis","volume":"28","author":"Kerti","year":"2013","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.bone.2025.117541_bb0320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2898","article-title":"Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome","volume":"46","author":"Tory","year":"2014","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bone.2025.117541_bb0325","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/archdischild-2016-312238","article-title":"Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study","volume":"102","author":"Matthews","year":"2017","journal-title":"Arch. Dis. Child."},{"issue":"5","key":"10.1016\/j.bone.2025.117541_bb0330","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0883073820972231","article-title":"Assessment of pediatric pseudotumor cerebri clinical characteristics and outcomes","volume":"36","author":"Yamamoto","year":"2021","journal-title":"J. Child Neurol."},{"issue":"2","key":"10.1016\/j.bone.2025.117541_bb0335","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12098-008-0029-2","article-title":"Hypophosphatasia associated with pseudotumor cerebri and respiratory insufficiency","volume":"75","author":"Teber","year":"2008","journal-title":"Indian J. Pediatr."},{"issue":"1","key":"10.1016\/j.bone.2025.117541_bb0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4274\/jcrpe.473","article-title":"Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report","volume":"4","author":"Demirbilek","year":"2012","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2025.117541_bb0345","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1651-2227.1970.tb09012.x","article-title":"Benign intracranial hypertension (pseudotumor cerebri). Review and report of 18 cases","volume":"59","author":"Hagberg","year":"1970","journal-title":"Acta Paediatr. Scand."},{"issue":"1","key":"10.1016\/j.bone.2025.117541_bb0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0034-1389900","article-title":"Intracranial hypertension in siblings with infantile hypercalcemia","volume":"46","author":"Dufek","year":"2015","journal-title":"Neuropediatrics"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822500153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822500153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:18:19Z","timestamp":1778941099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822500153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"alternative-id":["S875632822500153X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117541","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markedly discordant hypophosphatasia in a young girl","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117541"}}